DME (Diabetic Macular Edema)
Diabetic macular edema is a complication of diabetes that causes fluid to accumulate in the macula, the central part of the retina responsible for sharp, detailed vision. It is the most common cause of vision loss in people with diabetic retinopathy. Anti-VEGF injections are the standard of care and can stabilize or improve vision in most patients.
You may qualify for clinical trials that provide Eylea at no cost
Clinical trials may give you access to this treatment while helping advance medical research
Search TrialsSimilar to wet AMD, many commercial insurers require bevacizumab (Avastin) trial before branded anti-VEGF agents. Treatment typically begins with monthly injections for 3–6 months, then transitions to a treat-and-extend protocol. Steroid implants (Ozurdex, Iluvien) are reserved for anti-VEGF inadequate responders or pseudophakic eyes.
Anti-VEGF step therapy — must try Avastin before Eylea or Lucentis
Very Common
OCT imaging not submitted showing central subfield thickness
Common
Steroid implant (Ozurdex) denied without anti-VEGF failure
Common
Treatment frequency exceeds payer-allowed intervals
Occasional
HbA1c documentation required to confirm diabetes management
Occasional
- 1.Submit OCT showing central subfield thickness ≥300µm (or equivalent for your OCT device)
- 2.Document visual acuity and treatment response to prior anti-VEGF therapy
- 3.Include HbA1c and document diabetes management — insurers may deny if diabetes is uncontrolled
- 4.For Avastin step therapy appeals, document clinical rationale for branded agent (e.g., DME-specific FDA approval, dosing convenience)
- 5.Cite DRCR.net Protocol T data if requesting Eylea specifically for center-involving DME with poor visual acuity
Active clinical trials that may provide treatment at no cost.
Copay cards, patient assistance programs, and foundation grants for this condition's treatments.
Want to know what you'll actually pay?
Estimate your annual out-of-pocket cost with and without assistance programs.
Estimate My CostsDenied for DME (Diabetic Macular Edema) Treatment?
Ellen can decode your denial, find your appeal strategy, and generate your appeal letter — free.